Scotiabank Sticks to Their Buy Rating for Biomea Fusion (BMEA)

TipRanksNov 25 23:27 · Ratings

H.C. Wainwright Maintains Biomea Fusion(BMEA.US) With Buy Rating, Maintains Target Price $40

Futu NewsNov 21 19:31 · Ratings

Positive Buy Recommendation for Biomea Fusion Amid Promising Diabetes Treatment Developments in COVALENT-111 Phase 2 Trial

TipRanksNov 21 19:15

HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $40 Price Target

BenzingaNov 21 19:13 · Ratings

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow JonesNov 20 02:02 · Ratings

Biomea Fusion Price Target Maintained With a $128.00/Share by D. Boral Capital

Dow JonesNov 20 02:02 · Ratings